
October to December 2024
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| PEMBROLIZUMAB | $174,627,335 | 20,614 |
| ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR | $166,500,459 | 7,787 |
| USTEKINUMAB | $128,631,231 | 18,201 |
| DUPILUMAB | $121,900,013 | 71,027 |
| AFLIBERCEPT | $120,994,987 | 123,163 |
| NIVOLUMAB | $107,745,715 | 14,994 |
| SEMAGLUTIDE | $88,409,566 | 727,047 |
| DENOSUMAB | $82,397,875 | 325,023 |
| APIXABAN | $73,998,197 | 1,137,433 |
| MOLNUPIRAVIR | $72,289,917 | 61,041 |
| UPADACITINIB | $71,527,484 | 49,258 |
| NIRMATRELVIR (&) RITONAVIR | $64,770,305 | 53,057 |
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| ROSUVASTATIN | $39,029,572 | 4,248,267 |
| ATORVASTATIN | $30,705,336 | 2,990,372 |
| PANTOPRAZOLE | $29,208,767 | 2,899,246 |
| ESOMEPRAZOLE | $23,594,059 | 2,109,274 |
| ESCITALOPRAM | $9,168,897 | 1,690,003 |
| METFORMIN | $16,929,938 | 1,682,411 |
| PERINDOPRIL | $14,803,510 | 1,663,987 |
| SERTRALINE | $9,442,295 | 1,613,995 |
| CEFALEXIN | $8,375,558 | 1,298,356 |
| AMLODIPINE | $11,786,060 | 1,242,573 |
| AMOXICILLIN | $5,677,012 | 1,178,078 |
| APIXABAN | $73,998,197 | 1,137,433 |
| Contributor | Contribution Dollars |
|---|---|
| Australian Government | $5,177,736,039 |
| Patients | $805,814,095 |